Blood Plasma Market Report 2020 – Covering Impact of COVID-19, Financial Information, Developments, SWOT Analysis by Global Top Companies By 2025

The Blood Plasma Market is segmented on the lines of its product, application and regional. On the basis of product segmentation, it covers Immunoglobulin, Albumin, Protease Inhibitors, Coagulation factor concentrates and others. Based on application it is classified as Hospitals and clinics, Research Laboratories and Academic Institutions.

FYI, You will get latest updated report as per the COVID-19 Impact on this industry. Our updated reports will now feature detailed analysis that will help you make critical decisions.

The Blood Plasma Market is expected to exceed more than US$ 44.0 Billion by 2024 at a CAGR of 9.3% in the given forecast period.

Browse Full Report:

The Blood Plasma Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, and Rest of World. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

Plasma is the fluid part of the blood. Plasma is the flexible part and makes around 55% of the blood. Plasma is the composite blend of in excess of 700 proteins and different substances which are fundamental for the proficient working of the human body. Plasma helps in controlling body temperature and pulse. It fills in as a medium for trade of proteins, supplements and hormones to the diverse parts of the body. Clotting factor, albumin and immunoglobulin are some of the major proteins found in plasma.

The major driving factors of Blood Plasma Market are as follows:

  • Government and private organization support blood donation camps and programs to meet the rising demand of plasma
  • Rise in prevalence of bleeding disorders
  • Increasing kidney disorder that requires blood plasma product as a therapeutic

The major restraining factors of Blood Plasma Market are as follows:

  • Stringent regulatory standards on the import and export of plasma product
  • High complexity and cost associated with the collection of blood plasma
  • Dearth of skilled and trained professionals for fractionation procedure

The major opportunities of Blood Plasma Market are as follows:

  • Identification of new proteins in blood plasma to be used as therapeutic products are under clinical investigation
  • Exploring novel therapeutic application of the known blood plasma product to be used for other diseases

The Blood Plasma Market has been segmented as below:

The Blood Plasma Market is segmented on the lines of Product, Application and Regional Analysis.

By Product this market is segmented on the basis of Immunoglobulin, Albumin, Protease Inhibitors, Coagulation Factor Concentrates and Others. By Application this market is segmented on the basis of Hospitals and Clinics, Research Laboratories and Academic Institutions. By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World.

This report provides:

1) An overview of the global market for Blood Plasma Market and related technologies.
2) Analyses of global market trends, with data from 2015, estimates for 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2024.
3) Identifications of new market opportunities and targeted promotional plans for Blood Plasma Market

4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.

Report scope:

The scope of the report includes a detailed study of Blood Plasma Market with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Baxter International, CSL, Grifols, Octapharma, ADMA Biologics, Cerus Corp, Sanquin, Shanghai Raas and TCS Biosciences. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

Reasons to Buy this Report:

  1. Obtain the most up to date information available on all Blood Plasma Market.
  2. Identify growth segments and opportunities in the industry.
  3. Facilitate decision making on the basis of strong historic and forecast of Blood Plasma Market.
  4. Assess your competitor’s refining portfolio and its evolution.

Request Sample Report from here:

Table of Contents:

  1. Introduction
  2. Research Methodology
  3. Report Summary
  4. Market Overview

4.1    Introduction

4.2    Drivers

4.3    Restrains

4.4    Industry Trends

4.5    Porter’s Five Forces Analysis

  1. Blood Plasma Market Analysis, By Product
  2. Blood Plasma Market Analysis, By Application
  3. Blood Plasma Market Analysis, By Region
  4. Competitive Overview
  5. Company Profiles

9.1    Baxter International

9.2    CSL

9.3    Grifols

9.4    Octapharma

9.5    ADMA Biologics

9.6    Cerus Corp

9.7    Sanquin

9.8    Shanghai Raas

9.9    TCS Biosciences

Other Related Market Research Reports:

Blood Thinner Market Growth, Future Prospects and Competitive Analysis, 2018-2024

Blood Preparation Market is Forecast to Cross US$ 64.0 Billion by 2024


Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay


Phone: +1-855-984-1862

Country: United States